Analysts Viewpoint
Keros Therapeutics Inc (KROS) rating downgrades by BofA Securities
Keros Therapeutics Inc’s filing revealed that its 10% Owner ADAR1 Capital Management, LLC acquired Company’s shares for reported $9.46 million
Menu
Keros Therapeutics Inc’s filing revealed that its 10% Owner ADAR1 Capital Management, LLC acquired Company’s shares for reported $9.46 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Keros Therapeutics Inc’s recent filing unveils that its 10% Owner ADAR1 Capital Management, LLC acquired Company’s shares for reported $9.46
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Keros Therapeutics Inc’s filing revealed that its 10% Owner ADAR1 Capital Management, LLC acquired Company’s shares for reported $9.46 million